Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac IPO & Placement Research, China biotech

Northbound Flows Monthly (May): CMB, Yangtze Power, Yili

Northbound Flows: Biggest Inflow Since Feb

Northbound Flows: $5.7bn Inflows, Biggest Since Dec

Northbound Flows: CMB, China Yangtze Power, BYD, Longi Green Energy, SF Holding

Northbound Flows: Moutai, Zijin, Great Wall Motor

Northbound Flows: Big Sell on CATL After May Holiday

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Quantitative Analysis

China Industrials / Quantitative Analysis

<ul>
<li>We analyze the weekly Shanghai/Shenzhen northbound Connect flows with our data engine.</li>
<li>Consumer staple, health care, and information technology led the outflows of USD 1.3bn last week.</li>
<li>We highlight flows of COSCO Shipping, SF Holding, Yangtze Power, CMB, Wuliangye, Moutai.</li>
</ul>


We analyze the weekly Shanghai/Shenzhen northbound Connect flows with our data engine.
Consumer staple, health care, and information technology led the outflows of USD 1.3bn last week.
We highlight flows of COSCO Shipping, SF Holding, Yangtze Power, CMB, Wuliangye, Moutai.


Northbound Flows: COSCO Shipping, SF Holding, Yangtze Power, CMB, Wuliangye, Moutai